Fortress Biotech, Inc. (FBIO) financial statements and ratios from SEC XBRL: revenue $63.26M (TTM), net margin 10.8%, revenue growth 14.0% YoY, P/E 0.9. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $63.26M |
| Net Margin | 10.8% |
| Revenue Growth (YoY) | 14.0% |
| EPS Growth (YoY) | -116.0% |
| FCF Growth (YoY) | 115.4% |
| P/E Ratio | 0.9 |
| Price / Book | 0.46 |
| Price / Sales | 1.39 |
| FCF Yield | -62.2% |
| Altman Z-Score | -5.53 (distress) |
| Piotroski F-Score | 5/9 |
| Sector P/E (Healthcare) | 21.7 |
FBIO overview · FBIO earnings · FBIO KPIs · FBIO investor relations · FBIO ownership · FBIO peers · FBIO filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.